Literature DB >> 23050652

Activation of immune responses to brain antigens after stroke.

Kyra J Becker1.   

Abstract

Infection is common after stroke and is independently associated with a worse outcome. The predisposition to infection following stroke is in part related to a sympathetically mediated suppression of the peripheral immune response. The teleological explanation for this immune dysfunction is that it serves to prevent autoimmune responses to brain antigens. We believe that the systemic immune response in patients who develop infection, however, thwarts this seemingly protective response and predisposes to central nervous system autoimmunity. These autoimmune responses may mediate, at least in part, the worse outcome associated with post-stroke infection.
© 2012 The Author Journal of Neurochemistry © International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23050652      PMCID: PMC4138833          DOI: 10.1111/j.1471-4159.2012.07953.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  81 in total

1.  Fingolimod provides long-term protection in rodent models of cerebral ischemia.

Authors:  Ying Wei; Muge Yemisci; Hyung-Hwan Kim; Lai Ming Yung; Hwa Kyoung Shin; Seo-Kyoung Hwang; Shuzhen Guo; Tao Qin; Nafiseh Alsharif; Volker Brinkmann; James K Liao; Eng H Lo; Christian Waeber
Journal:  Ann Neurol       Date:  2010-11-12       Impact factor: 10.422

2.  Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke.

Authors:  Arthur Liesz; Wei Zhou; Éva Mracskó; Simone Karcher; Henrike Bauer; Sönke Schwarting; Li Sun; Dunja Bruder; Sabine Stegemann; Adelheid Cerwenka; Clemens Sommer; Alexander H Dalpke; Roland Veltkamp
Journal:  Brain       Date:  2011-03       Impact factor: 13.501

3.  Toll-like receptor, MHC II, B7 and cytokine expression by porcine monocytes and monocyte-derived dendritic cells in response to microbial pathogen-associated molecular patterns.

Authors:  Claudine R Raymond; Bruce N Wilkie
Journal:  Vet Immunol Immunopathol       Date:  2005-09-15       Impact factor: 2.046

4.  Reduced efficacy of circulating costimulatory cells after focal cerebral ischemia.

Authors:  Andreas Hug; Arthur Liesz; Bettina Muerle; Wei Zhou; Julia Ehrenheim; Alexander Lorenz; Alexander Dalpke; Roland Veltkamp
Journal:  Stroke       Date:  2011-09-29       Impact factor: 7.914

5.  Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection.

Authors:  Andreas Hug; Alexander Dalpke; Nina Wieczorek; Thomas Giese; Alexander Lorenz; Gerd Auffarth; Arthur Liesz; Roland Veltkamp
Journal:  Stroke       Date:  2009-08-06       Impact factor: 7.914

6.  CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke.

Authors:  Xuefang Ren; Kozaburo Akiyoshi; Arthur A Vandenbark; Patricia D Hurn; Halina Offner
Journal:  Metab Brain Dis       Date:  2010-11-17       Impact factor: 3.584

7.  Acute in vivo exposure to interferon-gamma enables resident brain dendritic cells to become effective antigen presenting cells.

Authors:  Andres Gottfried-Blackmore; Ulrike W Kaunzner; Juliana Idoyaga; Jennifer C Felger; Bruce S McEwen; Karen Bulloch
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-11       Impact factor: 11.205

8.  Different cytokine levels in thrombolysis patients as predictors for clinical outcome.

Authors:  G Mazzotta; P Sarchielli; V Caso; M Paciaroni; A Floridi; A Floridi; V Gallai
Journal:  Eur J Neurol       Date:  2004-06       Impact factor: 6.089

9.  Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial.

Authors:  S Aslanyan; C J Weir; H-C Diener; M Kaste; K R Lees
Journal:  Eur J Neurol       Date:  2004-01       Impact factor: 6.089

10.  The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia.

Authors:  Bozena Czech; Waltraud Pfeilschifter; Niloufar Mazaheri-Omrani; Marc André Strobel; Timo Kahles; Tobias Neumann-Haefelin; Abdelhaq Rami; Andrea Huwiler; Josef Pfeilschifter
Journal:  Biochem Biophys Res Commun       Date:  2009-08-29       Impact factor: 3.575

View more
  13 in total

1.  Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke.

Authors:  Christine Römer; Odilo Engel; Katarzyna Winek; Sonja Hochmeister; Tian Zhang; Georg Royl; Juliane Klehmet; Ulrich Dirnagl; Christian Meisel; Andreas Meisel
Journal:  J Neurosci       Date:  2015-05-20       Impact factor: 6.167

2.  Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases.

Authors:  Sungpil Han; Yen Chih Lin; Tianxia Wu; Alan D Salgado; Ina Mexhitaj; Simone C Wuest; Elena Romm; Joan Ohayon; Raphaela Goldbach-Mansky; Adeline Vanderver; Adriana Marques; Camilo Toro; Peter Williamson; Irene Cortese; Bibiana Bielekova
Journal:  J Immunol       Date:  2014-02-07       Impact factor: 5.422

Review 3.  The use of microRNAs to modulate redox and immune response to stroke.

Authors:  Yi-Bing Ouyang; Creed M Stary; Robin E White; Rona G Giffard
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

4.  A year-long immune profile of the systemic response in acute stroke survivors.

Authors:  Amy S Tsai; Kacey Berry; Maxime M Beneyto; Dyani Gaudilliere; Edward A Ganio; Anthony Culos; Mohammad S Ghaemi; Benjamin Choisy; Karim Djebali; Jakob F Einhaus; Basile Bertrand; Athena Tanada; Natalie Stanley; Ramin Fallahzadeh; Quentin Baca; Lisa N Quach; Elizabeth Osborn; Lauren Drag; Maarten G Lansberg; Martin S Angst; Brice Gaudilliere; Marion S Buckwalter; Nima Aghaeepour
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

Review 5.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

6.  Correction to: Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

7.  A complex role of herpes viruses in the disease process of multiple sclerosis.

Authors:  Simone C Wuest; Ina Mexhitaj; Noo Ri Chai; Elena Romm; Joerg Scheffel; Biying Xu; Kelly Lane; Tianxia Wu; Bibiana Bielekova
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

Review 8.  Oxidative Stress in Hypoxic-Ischemic Encephalopathy: Molecular Mechanisms and Therapeutic Strategies.

Authors:  Mingyi Zhao; Ping Zhu; Masayuki Fujino; Jian Zhuang; Huiming Guo; IdrisAhmed Sheikh; Lingling Zhao; Xiao-Kang Li
Journal:  Int J Mol Sci       Date:  2016-12-10       Impact factor: 5.923

Review 9.  Inflammatory responses in hypoxic ischemic encephalopathy.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Acta Pharmacol Sin       Date:  2013-07-29       Impact factor: 6.150

10.  Non-invasive tracking of CD4+ T cells with a paramagnetic and fluorescent nanoparticle in brain ischemia.

Authors:  Wei-Na Jin; Xiaoxia Yang; Zhiguo Li; Minshu Li; Samuel Xiang-Yu Shi; Kristofer Wood; Qingwei Liu; Ying Fu; Wei Han; Yun Xu; Fu-Dong Shi; Qiang Liu
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-19       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.